Pya Waltman Capital, LLC Amgen Inc Transaction History

Pya Waltman Capital, LLC

$276 Million
Q1 2025

A detailed history of Pya Waltman Capital, LLC transactions in Amgen Inc stock. As of the latest transaction made, Pya Waltman Capital, LLC holds 11,349 shares of AMGN stock, worth $3.23 Million. This represents 1.28% of its overall portfolio holdings.

Number of Shares

11,349

Previous 10,927 3.86%

Holding current value

$3.23 Million

Previous $2.85 Million 24.12%

% of portfolio

1.28%

Previous 1.05%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 01, 2025	BUY	$258.59 - $327.36 $109,124 - $138,145	422 Added 3.86%	11,349 $3.54 Million
Q4 2024 Feb 03, 2025	BUY	$258.78 - $328.31 $79,445 - $100,791	307 Added 2.89%	10,927 $2.85 Million
Q3 2024 Nov 15, 2024	BUY	$309.38 - $337.38 $136,745 - $149,121	442 Added 4.34%	10,620 $3.42 Million
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $167,371 - $203,400	637 Added 6.68%	10,178 $3.18 Million
Q1 2024 May 13, 2024	BUY	$268.87 - $324.56 $362,167 - $437,182	1,347 Added 16.44%	9,541 $2.71 Million
Q4 2023 Feb 05, 2024	BUY	$255.7 - $288.46 $137,822 - $155,479	539 Added 7.04%	8,194 $2.36 Million
Q3 2023 Nov 13, 2023	BUY	$218.65 - $271.46 $335,190 - $416,148	1,533 Added 25.04%	7,655 $2.06 Million
Q2 2023 Aug 15, 2023	BUY	$214.27 - $253.37 $348,403 - $411,979	1,626 Added 36.17%	6,122 $1.36 Million
Q1 2023 May 09, 2023	BUY	$225.79 - $275.2 $348,845 - $425,184	1,545 Added 52.36%	4,496 $1.09 Million
Q4 2022 Feb 14, 2023	BUY	$229.03 - $291.01 $122,531 - $155,690	535 Added 22.14%	2,951 $775,000
Q3 2022 Nov 04, 2022	BUY	$224.46 - $253.15 $384,948 - $434,152	1,715 Added 244.65%	2,416 $545,000
Q2 2022 Aug 12, 2022	BUY	$230.71 - $256.74 $127,121 - $141,463	551 Added 367.33%	701 $171,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $29,832 - $34,140	150 New	150 $34,000

Others Institutions Holding AMGN

# of Institutions

3,271

Shares Held

445M

Call Options Held

7.23M

Put Options Held

6.71M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $152B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pya Waltman Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pya Waltman Capital, LLC with notifications on news.

Account

Pya Waltman Capital, LLC Amgen Inc Transaction History